ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Zolmitriptan N-Oxide
Zolmitriptan N-Oxide
![Zolmitriptan N-Oxide Structure](CAS/GIF/251451-30-6.gif)
- CAS No.
- 251451-30-6
- Chemical Name:
- Zolmitriptan N-Oxide
- Synonyms
- Zolmitriptan N-Oxide;Zolmitriptan USP RC E;Zolmitriptan Impurity B;Zomitriptan EP impurity B;Zolmitriptan EP Impurity B;Zolmitriptan USP Related Compound E;Zolmitriptan Impurity 1(Zolmitriptan USP RC E);Zolmitriptan USP Related Compound E (N-Oxide );Zolmitriptan EP Impurity B (Zolmitriptan N-Oxide);(4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinon
- CBNumber:
- CB11176862
- Molecular Formula:
- C16H21N3O3
- Molecular Weight:
- 303.36
- MOL File:
- 251451-30-6.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/5/4 15:13:19
Melting point | >185°C (dec.) |
---|---|
storage temp. | -20°C Freezer, Under Inert Atmosphere |
solubility | Methanol (Slightly), Water (Slightly) |
form | Solid |
pka | 12.55±0.40(Predicted) |
color | White |
CAS DataBase Reference | 251451-30-6 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P264-P270-P301+P312-P330-P501 |
HS Code | 2934990002 |
Zolmitriptan N-Oxide Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 45)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Varanous Labs Pvt Ltd | +91-7036248882 +91-7036248882 | Hyderabad, India | 1541 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
sgtlifesciences pvt ltd | +8617013299288 | China | 12382 | 58 | Inquiry |
Alfa Chemistry | +1-5166625404 | United States | 21317 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
Shanghai Zerui Biotechnology Co., Ltd. | 021-54580889 18321124657 | China | 10614 | 58 | Inquiry |
Hangzhou Yaoruiyicheng Biological Medicine Co., Ltd | 18072846723 | China | 18924 | 58 | Inquiry |
BOC Sciences | 1-631-485-4226; 16314854226 | United States | 14059 | 65 | Inquiry |
251451-30-6(Zolmitriptan N-Oxide)Related Search:
(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone
BENZENEPROPANOL, B,4-DIAMINO-, (S)-
4-aminobutanal
Zolmitriptan
Zolmitriptan Related Compound D (20 mg) ((S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate)
Didesmethyl Zolmitriptan
Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)
Zolmitriptan Related Compound F
(S)-4-(4-Hydrazinylbenzyl)-2-oxazolidinone
Zolmitriptan
chevron_left
1of4
chevron_right
Zolmitriptan N-Oxide
(4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone
(4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinon
Zolmitriptan USP RC E
Zolmitriptan USP Related Compound E
Zolmitriptan EP Impurity B/Zolmitriptan N-Oxide/Zolmitriptan USP Related Compound E
Zolmitriptan Impurity 1(Zolmitriptan USP RC E)
N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine oxide
(S)-N,N-dimethyl-2-(5-((2-oxooxazolidin-4-yl)methyl)-1H-indol-3-yl)ethanamine oxide
Zolmitriptan EP Impurity B
2-Oxazolidinone, 4-[[3-[2-(dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-
Zolmitriptan EP Impurity B (Zolmitriptan N-Oxide)
Zolmitriptan USP Related Compound E (N-Oxide )
Zolmitriptan EP Impurity B/ Zolmitriptan Related Compound E (Zolmitriptan N-Oxide)
Zolmitriptan Related Compound E ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl (1727064)
(S)-N,N-dimethyl-2-(5-((2-oxooxazolidin-4-yl)methyl)-1H-indol-3-yl)ethan-1-amine oxide
Zolmitriptan Impurity B
Zomitriptan EP impurity B
251451-30-6
2511451-30-6
Various Metabolites and Impurities
Intermediates & Fine Chemicals
Metabolites & Impurities
Pharmaceuticals